Ellagic acid supplementation in patient with irritabe bowel syndrome

Phase 3

• Conditions: Irritable bowel syndrome.; Irritable bowel syndrome with diarrhea; K58.0

• Registration Number: IRCT20141025019669N11
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Men and women with irritable bowel syndrome

Exclusion Criteria

Patients with gastrointestinal problems such as celiac disease and infection of the gastrointestinal tract

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Antioxidant indices. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.;Quality of life. Timepoint: Before intervention and after intervention. Method of measurement: Irritable Bowel Syndrome Quality of Life Questionnaire.;Sleep quality. Timepoint: Before intervention and after intervention. Method of measurement: Petersburg’s sleep quality questionnaire.;Inflammatory factors. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.